M. Ansaldi et al., TorC apocytochrome negatively autoregulates the trimethylamine N-oxide (TMAO) reductase operon in Escherichia coli, MOL MICROB, 33(2), 1999, pp. 284-295
The trimethylamine N-oxide (TMAO) anaerobic respiratory system of Escherich
ia coil comprises a periplasmic terminal TMAO reductase (TorA) and a pentah
aem c-type cytochrome (TorC), which is involved in electron transfer to Tor
A, The structural proteins are encoded by the torCAD operon whose expressio
n is induced in the presence of TMAO through the TorS/TorR two-component sy
stem. By using a genomic library cloned into a multicopy plasmid, we identi
fied TorC as a possible negative regulator of the tor operon, Interestingly
, in trans overexpression of torC not only decreased the activity of a torA
'-'lacZ fusion, but also dramatically reduced the amount of mature TorC cyt
ochrome, This led us to propose that, after translocation, TorC apocytochro
me downregulates the for operon unless it is properly matured, In agreement
with this hypothesis, we have shown that mini-Tn10 insertions within genes
involved in the c-type cytochrome maturation pathway or haem biosynthesis
decreased for operon expression, Dithiothreitol (DTT), which reduces disulp
hide bonds and thus prevents the first step in c-type cytochrome formation,
also strongly decreases the for promoter activity, The DTT effect is TorC
dependent, as it is abolished when torC is disrupted, In contrast, overexpr
ession of the c-type cytochrome maturation (ccm) genes relieved the for ope
ron of the negative control and allowed the bacteria to produce a higher am
ount of TorC holocytochrome, Therefore, the TorC negative autoregulation pr
obably means that maturation of the c-type cytochrome is a limiting step fo
r Tor system biogenesis. Genetic experiments have provided evidence that To
rC control is mediated by the TorS/TorR two-component system and different
from the for anaerobic control. In our working model, TMAO and apoTorC bind
to the periplasmic side of TorS, but TMAO activates TorS autophosphorylati
on, whereas apoTorC inhibits the TorS kinase activity.